$16.52
-0.43-2.54%
Last update: Nov 10, 4:41 PM
Beta Bionics Inc
BBNXNASDAQ
Beta Bionics fell 41.2% from $28.82 to $16.95, behind the S&P 500's +9.8%. Its worst day was Jan 9 (−37.0%), and its low came Apr 10 at $8.86.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Beta Bionics closed at its highest level of the year, 11.0% above where the year started.
+1.6% · S&P 500 0.0%
EPS of $-0.30 beat the $-0.39 estimate on $32.1M revenue (est. $31.5M); FY revenue guidance of $130.0M–$135.0M against the $118.7M consensus.
Story events cover the past 12 months · Times ET
−2.6% · S&P 500 +0.5%
Beta Bionics closed at its lowest level of the year, 69.3% below where the year started.
−8.0% · S&P 500 −0.1%
EPS of $-0.49 missed the $-0.48 estimate on $27.6M revenue (est. $27.3M); FY revenue guidance of $131.0M–$136.0M against the $132.6M consensus.
−0.6% · S&P 500 +1.0%
EPS of $-0.53 beat the $-0.56 estimate on $32.0M revenue (est. $31.5M); FY revenue guidance of $131.0M–$136.0M against the $133.6M consensus.
−5.9% · S&P 500 +1.7%
Beta Bionics shares rose 15.3%, while the S&P 500 fell 0.4%.
+15.3% · S&P 500 −0.4%
EPS of $-0.52 beat the $-0.52 estimate on $35.5M revenue (est. $34.7M); FY revenue guidance of $124.0M–$126.0M against the $125.7M consensus.
−16.5% · S&P 500 +0.3%
Where it ended: a close of $16.95 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 16, 2027 (EPS est. $-0.44, revenue est. $30.4M).
Nothing in the past 12 months.
All BBNX dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BBNX and SPY from Benzinga historical bars. Not investment advice.
